ActivSight Intelligent Light attaches to laparoscopic systems to provide real-time, on-demand surgical insights. Credit: Activ Surgical / Business Wire.

Activ Surgical has announced receipt of CE Mark approval for its enhanced imaging system, ActivSight Intelligent Light.

The approval of the easy-to-adapt module validates that it meets the requirements of the European Medical Devices Regulation.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Activ Surgical will now be able to commercialise ActivSight across the European Union and other regions where the CE Mark is required.

Designed to be a routine part of surgical practice, ActivSight attaches to existing laparoscopic systems and provides on-demand, real-time surgical insights.

It is said to be the first and only modular form factor with multimodal advanced visualisation for surgeries that are minimally invasive.

A hardware-agnostic module, ActivSight provides surgeons with critical intraoperative visual data and imaging to help improve patient safety and outcomes in the operating room.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Activ Surgical CEO Todd Usen said: “The team at Activ Surgical is thrilled to achieve the CE Mark for ActivSight in the European Union and beyond.

“This clearance represents a momentous step forward for the company as we execute against our global commercialisation strategy for the system.

“We believe ActivSight will be a game-changer in the operating room by revolutionising surgical vision and, ultimately, improving surgical care and patient safety.”

Using ActivSight, surgeons can augment their senses with the help of reality overlays.

Last year, the US Food and Drug Administration (FDA) granted 510(k) clearance for ActivSight, which has already seen clinical use in more than 200 patients and multiple in-human institutional review board (IRB) trials successfully.

Currently, several major US and European hospital networks have been established as pilot sites for the system.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact